News
4d
News Medical on MSNNK cells with bispecific antibody yield high response rates in patients with lymphoma: Clinical trialA novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
New research reveals 5 ways exercise enhances cancer treatment effectiveness, offering hope to patients with chronic ...
Scientists at the University of Minnesota have made an exciting discovery that could help improve cancer treatment. They ...
A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...
Cells don’t just follow a rigid script when responding to stress – they’re far more adaptable than we thought. A new study ...
An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in ...
Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...
First NK Cell Therapy Approval Expected By 2028 Says Kuick Research In Its New Research Study On Global NK Cell Therapy ...
Cord blood units for each cycle, used for the NK cells, were selected from the MD Anderson Cancer Center Cord Blood Bank and chosen based on the criteria previously identified for optimal cord ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results